Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes

Diabetologia

Volumn 59, Issue 1, 2016, Pages 208-216

  Hadjadj, Samy ^a,b,c   Cariou, Bertrand ^d,e   Fumeron, Frederic ^e,f,g   Gand, Elise ^b   Charpentier, Guillaume ^h,i   Roussel, Ronan ^e,f,g   Kasmi, Ahmed Amine ^a,b,c   Gautier, Jean François ^e,f,j   Mohammedi, Kammel ^e,f,g   Gourdy, Pierre ^e,k   Saulnier, Pierre Jean ^a,b,c   Feigerlova, Eva ^a,b,c   Marre, Michel ^e,f,g  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e L INSTITUT DU THORAX   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g BICHAT HOSPITAL   (France)

^h CENTRE HOSPITALIER SUD FRANCILIEN   (France)

ⁱ Centre for Study and Research for Improvement of the Treatment of Diabetes CERITD   (France)

^j HÔPITAL LARIBOISIÈRE   (France)

^k TOULOUSE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Death; Diabetic complications; Diabetic nephropathy; Renal function decline; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; COHORT ANALYSIS; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FRANCE; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTOR; STATISTICAL MODEL; URINE;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FRANCE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEINURIA; RISK FACTORS;

EID: 84949323620     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3785-3     Document Type: Article

References (26)

1. The expert Committee on the diagnosis and classification of diabetes mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
2. Groop PH, Thomas MC, Moran JL et al (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58:1651–1658
3. Orchard TJ, Secrest AM, Miller RG, Costacou T (2010) In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 53:2312–2319
4. Afkarian M, Sachs MC, Kestenbaum B et al (2013) Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 24:302–308
5. Ninomiya T, Perkovic V, de Galan BE et al (2009) Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20:1813–1821
6. Gale EA (2006) Declassifying diabetes. Diabetologia 49:1989–1995
7. Hasslacher C, Ritz E, Wahl P, Michael C (1989) Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant 4:859–863
8. Levey AS, Inker LA, Matsushita K et al (2014) GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 64:821–835
9. Skupien J, Warram JH, Smiles AM, et al (2012) The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Kidney Int 82:589–597
10. Hadjadj S, Péan F, Gallois Y et al (2004) Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care 27:2661–2668
11. Marre M, Jeunemaitre X, Gallois Y et al (1997) Contribution of genetic polymorphism in the renin–angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest 99:1585–1595
12. de Hauteclocque A, Ragot S, Slaoui Y et al (2014) The influence of sex on renal function decline in people with type 2 diabetes. Diabet Med 31:1121–1128
13. Lièvre M, Marre M, Chatellier G et al (2000) The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and Ramipril (DIABHYCAR) Study: design, organization, and patient recruitment. Control Clin Trials 21:383–396
14. Marre M, Lievre M, Chatellier G, Mann JF, Passa P, Menard J (2004) Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). BMJ 328:495
15. Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85:49–61
16. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
17. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63:225–232
18. Forsblom C, Harjutsalo V, Thorn LM et al (2011) Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 22:537–544
19. Biesenbach G, Hubmann R, Grafinger P, Stuby U, Eichbauer-Sturm G, Janko O (2000) 5-year overall survival rates of uremic type 1 and type 2 diabetic patients in comparison with age-matched nondiabetic patients with end-stage renal disease from a single dialysis center from 1991 to 1997. Diabetes Care 23:1860–1862
20. Pugh JA, Medina R, Ramirez M (1993) Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 36:1094–1098
21. Eriksson J, Forsen B, Haggblom M, Teppo AM, Groop L (1992) Clinical and metabolic characteristics of type 1 and type 2 diabetes: an epidemiological study from the Narpes community in western Finland. Diabet Med 9:654–660
22. Penfornis A, Personeni E, Tiv M et al (2012) Quality of care of patients with type 1 diabetes: population-based results in a French region. Diabetes Metab 38:436–443
23. Saulnier PJ, Gand E, Ragot S et al (2014) Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care 37:1425–1431
24. Pezzolesi MG, Poznik GD, Mychaleckyj JC et al (2009) Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes 58:1403–1410
25. Maeda S, Araki S, Babazono T et al (2010) Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes 59:2075–2079
26. Hur J, Nair V, Brosius F, Kretzler M, Feldman EL (2015) Shared transcriptional networks between diabetic peripheral neuropathy and nephropathy in murine models of diabetes [abstract]. Diabetes 64(suppl 1):A50